A rebuttal of Flottorp et al. “New NICE guideline on chronic fatigue syndrome: more ideology than science?”
Flottorp and colleagues have published a commentary in the Lancet in which they criticize the
Author: ME/CFS skeptic
The dark psychosomatic history of cancer part II
Since ancient times, the onset of cancer has been linked to depression and melancholia. Hopelessness,
Continue readingThe dark psychosomatic history of cancer part II
The dark psychosomatic history of cancer part I
Since ancient times, the onset of cancer has been linked to depression and melancholia. Hopelessness,
Continue readingThe dark psychosomatic history of cancer part I
2021: Looking back on a year of ME/CFS research
It’s the end of December, so time to review the most interesting scientific research findings
Continue reading2021: Looking back on a year of ME/CFS research
A historic change for the ME/CFS community
Today, on 29 October 2021, the National Institute for Health and Care Excellence (NICE) has
A summary of the Massachusetts ME/CFS conference
On 23 October 2021, the Massachusetts ME/CFS & FM Association organized an online conference titled
Continue readingA summary of the Massachusetts ME/CFS conference
InTime: the results of Cortene’s CT38 trial
Cortene Inc., an American pharmaceutical company, recently published findings of a preliminary treatment trial in
Comments on the CDC evidence review on ME/CFS
In a previous blog post, we summarized the draft report of a systematic review on
Continue readingComments on the CDC evidence review on ME/CFS
Summary of the CDC evidence review
The Centers for Disease Control and Prevention (CDC) have commissioned a systematic review on the
Problems with the MetaBLIND study
The MetaBLIND study is likely the largest study on the effect of blinding in randomized